These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 2225722)

  • 1. Role of glucagon in the splanchnic and systemic hemodynamic changes induced by portal-systemic blood shunting.
    Romeo JM; Lopez-Farre A; Martin-Paredero V; Lopez-Novoa JM
    Clin Physiol Biochem; 1990; 8(3):144-52. PubMed ID: 2225722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased blood flow through the portal system in cirrhotic rats.
    Vorobioff J; Bredfeldt JE; Groszmann RJ
    Gastroenterology; 1984 Nov; 87(5):1120-6. PubMed ID: 6479534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The role of nitric oxide in hyperdynamic circulation in portal hypertensive rats].
    Wu Z; Zhou J; Chen Z; Zhou H; Jiao Z; Kuang Y; Yuan J; Wang Q; Zeng M
    Zhonghua Wai Ke Za Zhi; 1998 Mar; 36(3):182-6. PubMed ID: 11825365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Splanchnic and systemic hemodynamic alterations in chronic, progressive portal hypertensive rats.
    Blanchart A; Garrido MC; Fernández-Muñoz D; Nuño J; Hernando L; López-Novoa JM
    Rev Esp Fisiol; 1984 Dec; 40(4):493-9. PubMed ID: 6397796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hyperdynamic status in a partial portal vein ligated (PVL) rat's portal hypertension model].
    Wang CT; Kuang YL; Chen ZP
    Zhonghua Wai Ke Za Zhi; 1994 Sep; 32(9):573-5. PubMed ID: 7720436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of portasystemic shunts in the hyperkinetic circulation of the portal hypertensive rat.
    Braillon A; Lee SS; Girod C; Peignoux-Martinot M; Valla D; Lebrec D
    J Lab Clin Med; 1986 Dec; 108(6):543-8. PubMed ID: 3783027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulatory effects of graded diversion of portal blood flow to the systemic circulation in rats: role of nitric oxide.
    Bernadich C; Bandi JC; Piera C; Bosch J; Rodes J
    Hepatology; 1997 Aug; 26(2):262-7. PubMed ID: 9252132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of somatostatin on splanchnic hemodynamics and plasma glucagon in portal hypertensive rats.
    Kravetz D; Bosch J; Arderiu MT; Pizcueta MP; Casamitjana R; Rivera F; Rodés J
    Am J Physiol; 1988 Mar; 254(3 Pt 1):G322-8. PubMed ID: 2894777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of nitric oxide inhibitor on prostacyclin biosynthesis in portal hypertensive rats.
    Cao H; Wu Z; Zhou J; Chen Z; Kuang Y
    Chin Med J (Engl); 1999 Jun; 112(6):516-9. PubMed ID: 11601330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of nitric oxide synthase and cyclooxygenase blockade on expression of cyclooxygenase and hemodynamics in rats with portal hypertension.
    Cao H; Xu J; Liu H; Meng FB; Qiu JF; Wu ZY
    Hepatobiliary Pancreat Dis Int; 2006 Nov; 5(4):564-9. PubMed ID: 17085343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of overproduction of plasma prostacyclin in portal hypertensive rats.
    Cao H; Wu Z; Zhou J; Jiao Z; Chen Z; Kuang Y
    Chin Med J (Engl); 1998 Dec; 111(12):1064-7. PubMed ID: 11263364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of glucagon on systemic and splanchnic circulation in conscious rats with biliary cirrhosis.
    Cerini R; Koshy A; Hadengue A; Lee SS; Garnier P; Lebrec D
    J Hepatol; 1989 Jul; 9(1):69-74. PubMed ID: 2768797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Portal-systemic shunting and hemodynamics of prehepatic portal hypertensive rat models].
    Zhou YB; Leng X; Qi G
    Zhonghua Wai Ke Za Zhi; 1997 Apr; 35(4):244-7. PubMed ID: 10374550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation of the hemodynamic effects of tumor necrosis factor alpha factor in rats with portal hypertension using the radioactive microsphere technique].
    Pérez-Páramo M; Muñoz J; Albillos A; Rossi I; Alvarez-Mon M; Ortiz Berrocal J
    Rev Esp Med Nucl; 1998; 17(4):294-301. PubMed ID: 9721346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of VEGF receptor-2 decreases the development of hyperdynamic splanchnic circulation and portal-systemic collateral vessels in portal hypertensive rats.
    Fernandez M; Mejias M; Angermayr B; Garcia-Pagan JC; Rodés J; Bosch J
    J Hepatol; 2005 Jul; 43(1):98-103. PubMed ID: 15893841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Splanchnic endotoxin levels in cirrhotic rats induced by carbon tetrachloride.
    Chu CJ; Lee FY; Wang SS; Chang FY; Lin HC; Lu RH; Chan CC; Lee SD
    Zhonghua Yi Xue Za Zhi (Taipei); 2000 Mar; 63(3):196-204. PubMed ID: 10746415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperdynamic circulation in portal-hypertensive rat model: a primary factor for maintenance of chronic portal hypertension.
    Vorobioff J; Bredfeldt JE; Groszmann RJ
    Am J Physiol; 1983 Jan; 244(1):G52-7. PubMed ID: 6849394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of long-term administration of octreotide in portal vein-stenosed rats.
    Lin HC; Yang MC; Hou MC; Li SM; Huang YT; Yu PC; Tsai YT; Lee SD
    Hepatology; 1996 Mar; 23(3):537-43. PubMed ID: 8617434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperglucagonemia and hyperdynamic circulation in rats with biliary cirrhosis.
    Ohara N; Jaspan J; Chang SW
    J Lab Clin Med; 1993 Jan; 121(1):142-7. PubMed ID: 8426077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of ritanserin, a selective and specific S2-serotonergic antagonist, on portal pressure and splanchnic hemodynamics in portal hypertensive rats.
    Nevens F; Pizcueta MP; Fernández M; Bosch J; Rodés J
    Hepatology; 1991 Dec; 14(6):1174-8. PubMed ID: 1959867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.